Investigating the effect of PRP in oligospermia
Phase 3
Recruiting
- Conditions
- Oligostenoteratozoospermia.Male infertility
- Registration Number
- IRCT20220317054318N2
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 88
Inclusion Criteria
Age range 20-45 years.
sperm count less than 20 million,
Movement less than 106 x 5 ml, progressive movement < 20%, normal morphology < 10%
Exclusion Criteria
Receiving other treatments for oligospermia such as hormone therapy
Suffering from underlying diseases (such as diabetes, kidney disease, liver disease, drug and alcohol addiction) and types of cancer and receiving chemotherapy treatments
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sperm count and motility in men. Timepoint: 3 months after intratesticular platelet rich plasma injection. Method of measurement: Sperm analysis, DNA fragmentation index.
- Secondary Outcome Measures
Name Time Method